MedPath

陕西同康药业有限公司

Ownership
-
Established
2004-03-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

62

NMPA:62

Drug Approvals

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61022023
Approval Date
Nov 24, 2022
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H61020216
Approval Date
Nov 24, 2022
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61022024
Approval Date
Nov 24, 2022
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H61020222
Approval Date
Mar 31, 2022
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H61021397
Approval Date
Mar 31, 2022
NMPA

Moroxydine Hydrochloride Tablets

Product Name
盐酸吗啉胍片
Approval Number
国药准字H61023548
Approval Date
Mar 31, 2022
NMPA

Glucosum Pro Orale

Product Name
口服葡萄糖
Approval Number
国药准字H61021857
Approval Date
Mar 31, 2022
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61020485
Approval Date
Mar 31, 2022
NMPA

Tabellae acidi Oleanolici

Product Name
齐墩果酸片
Approval Number
国药准字H61021861
Approval Date
Feb 10, 2022
NMPA

Tabellae Oxytetracyclini

Product Name
土霉素片
Approval Number
国药准字H61022020
Approval Date
Feb 10, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.